As per the insider financial article, NPHC secu
Post# of 102

Quote:
NPHC secures cash flow selling an already acquired portfolio of OTC pain drugs while financing revolutionary treatments. Shareholders can profit from an already established business model, and also have chances of making significant returns if the FDA approves the new therapies.

